176 related articles for article (PubMed ID: 34852705)
21. SNHG7 accelerates cell migration and invasion through regulating miR-34a-Snail-EMT axis in gastric cancer.
Zhang Y; Yuan Y; Zhang Y; Cheng L; Zhou X; Chen K
Cell Cycle; 2020 Jan; 19(1):142-152. PubMed ID: 31814518
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-223-5p targets long non-coding RNA TP73 antisense RNA1 to promote the invasion of gastric cancer.
Liu J; Wang H; Liao X
Hum Cell; 2020 Jul; 33(3):676-682. PubMed ID: 32248369
[TBL] [Abstract][Full Text] [Related]
23. The role of lncRNA CERS6-AS1 in cancer and its molecular mechanisms: A systematic review and meta-analysis.
Rastad H; Samimisedeh P; Alan MS; Afshar EJ; Ghalami J; Hashemnejad M; Alan MS
Pathol Res Pract; 2023 Jan; 241():154245. PubMed ID: 36580796
[TBL] [Abstract][Full Text] [Related]
24. The role and clinical significance of long noncoding RNA zinc finger E-box-binding homeobox two antisense RNA 1 in promoting osteosarcoma cancer cell proliferation, inhibiting apoptosis and increasing migration by regulating miR-145.
Zhou Y; Feng D; Gu X; Gao A; Liu Y
Anticancer Drugs; 2021 Feb; 32(2):168-177. PubMed ID: 32826416
[TBL] [Abstract][Full Text] [Related]
25. LncRNA CADM1-AS1 serves as a new prognostic biomarker for gastric cancer.
Shi XY; Sun YZ; Li M; Li HY
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):232-238. PubMed ID: 31389606
[TBL] [Abstract][Full Text] [Related]
26. Long non-coding RNA SBF2-AS1 promotes hepatocellular carcinoma progression through regulation of miR-140-5p-TGFBR1 pathway.
Li Y; Liu G; Li X; Dong H; Xiao W; Lu S
Biochem Biophys Res Commun; 2018 Sep; 503(4):2826-2832. PubMed ID: 30115383
[TBL] [Abstract][Full Text] [Related]
27. Long non-coding RNA CERS6-AS1 facilitates the oncogenicity of pancreatic ductal adenocarcinoma by regulating the microRNA-15a-5p/FGFR1 axis.
Yun Z; Meng F; Li S; Zhang P
Aging (Albany NY); 2021 Feb; 13(4):6041-6054. PubMed ID: 33581689
[TBL] [Abstract][Full Text] [Related]
28. MAFG-AS1 is a novel clinical biomarker for clinical progression and unfavorable prognosis in gastric cancer.
Li C; Wu R; Xing Y
Cell Cycle; 2020 Mar; 19(5):601-609. PubMed ID: 32079456
[TBL] [Abstract][Full Text] [Related]
29. MiR-6872 host gene SEMA3B and its antisense lncRNA SEMA3B-AS1 function synergistically to suppress gastric cardia adenocarcinoma progression.
Guo W; Liang X; Liu L; Guo Y; Shen S; Liang J; Dong Z
Gastric Cancer; 2019 Jul; 22(4):705-722. PubMed ID: 30656427
[TBL] [Abstract][Full Text] [Related]
30. LncRNA TP73-AS1 accelerates tumor progression in gastric cancer through regulating miR-194-5p/SDAD1 axis.
Ding Z; Lan H; Xu R; Zhou X; Pan Y
Pathol Res Pract; 2018 Dec; 214(12):1993-1999. PubMed ID: 30279010
[TBL] [Abstract][Full Text] [Related]
31. Long noncoding RNA CERS6-AS1 functions as a malignancy promoter in breast cancer by binding to IGF2BP3 to enhance the stability of CERS6 mRNA.
Bao G; Huang J; Pan W; Li X; Zhou T
Cancer Med; 2020 Jan; 9(1):278-289. PubMed ID: 31701672
[TBL] [Abstract][Full Text] [Related]
32. Upregulation of long non-coding RNA ROR1-AS1 promotes cell growth and migration in bladder cancer by regulation of miR-504.
Chen Q; Fu L
PLoS One; 2020; 15(1):e0227568. PubMed ID: 31929567
[TBL] [Abstract][Full Text] [Related]
33. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
[TBL] [Abstract][Full Text] [Related]
34. YY1-induced long non-coding RNA PSMA3 antisense RNA 1 functions as a competing endogenous RNA for microRNA 214-5p to expedite the viability and restrict the apoptosis of bladder cancer cells via regulating programmed cell death-ligand 1.
Zhang M; Xu Y; Yin S; Qiu F
Bioengineered; 2021 Dec; 12(2):9150-9161. PubMed ID: 34720049
[TBL] [Abstract][Full Text] [Related]
35. Significance of long non-coding RNA IFNG-AS1 in the progression and clinical prognosis in colon adenocarcinoma.
Wang Z; Cao Z; Wang Z
Bioengineered; 2021 Dec; 12(2):11342-11350. PubMed ID: 34872454
[TBL] [Abstract][Full Text] [Related]
36. Long noncoding RNA CERS6-AS1 modulates glucose metabolism and tumor progression in hepatocellular carcinoma by promoting the MDM2/p53 signaling pathway.
Xu B; Wei Y; Liu F; Li L; Zhou S; Peng Y; Li B
Cell Death Discov; 2022 Aug; 8(1):348. PubMed ID: 35927226
[TBL] [Abstract][Full Text] [Related]
37. LncRNA DARS-AS1 regulates microRNA-129 to promote malignant progression of thyroid cancer.
Zheng W; Tian X; Cai L; Shen YM; Cao QS; Yang JY; Tian GY
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10443-10452. PubMed ID: 31841198
[TBL] [Abstract][Full Text] [Related]
38. Clinical Potential of lncRNA PPP1R26-AS1 in Breast Cancer and Its Contribution to Cancer Progression.
Zhou S; Zhang S; Zhang H; Ma J; Dai H; Qu L; Zhou M
Mol Biotechnol; 2022 Jun; 64(6):660-669. PubMed ID: 35064892
[TBL] [Abstract][Full Text] [Related]
39. Long non-coding RNA HAND2-AS1 inhibits gastric cancer progression by suppressing TCEAL7 expression via targeting miR-769-5p.
Yu L; Luan W; Feng Z; Jia J; Wu Z; Wang M; Li F; Li Z
Dig Liver Dis; 2021 Feb; 53(2):238-244. PubMed ID: 32952069
[TBL] [Abstract][Full Text] [Related]
40. LncRNA FEZF1-AS1 Modulates Cancer Stem Cell Properties of Human Gastric Cancer Through miR-363-3p/HMGA2.
Hui Y; Yang Y; Li D; Wang J; Di M; Zhang S; Wang S
Cell Transplant; 2020; 29():963689720925059. PubMed ID: 32638620
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
